"Over the last few years the society recognized the need to have nuclear medicine--and in particular PET imaging--used in more clinical trials. We have also recognized the need to help further this technology for drug development," said SNM President Peter S. Conti, M.D., Ph.D. "As we developed this concept, we looked for an experienced imaging core lab to help support our endeavors and to collaborate in this process. Bio-Imaging has a reputation of operational and scientific experience, and we are pleased to invite them to work with the Society of Nuclear Medicine," added Conti, a professor of radiology, clinical pharmacy and biomedical engineering at the University of Southern California, Los Angeles.
"This important collaboration will help the continued success of nuclear medicine in clinical practice, in drug development and in the emerging molecular imaging field," agreed SNM Vice President-Elect Alexander J. McEwan, M.D., chair of the society's Molecular Imaging and Radionuclide Therapy Trials.
Mark L. Weinstein, president and chief executive officer of Bio-Imaging, noted, "We are very pleased that SNM has chosen to partner with us. We have appreciated the role of nuclear medicine imaging in the drug and medical device development process for some time, and this will allow us to become more involved in an area that is growing and developing rapidly."
"We believe nuclear medicine utilization will continue to grow and become more acceptable to the Food and Drug Administration (FDA) for assessing the efficacy and safety of new drugs, biologics and medical devices," added Colin G. Miller, Ph.D., Bio-Imaging senior vice president of business development. "Through this collaboration, access to the expertise within the society will also allow us to expand the group of experts and consultants who provide support to our clients. Furthermore, we have identified a number of discrete initiatives on which we are starting to collaborate that will enhance our experience and help develop the use of nuclear medicine in clinical trials. Bio-Imaging education programs are also an area of collaboration with SNM," said Miller.
About the Society of Nuclear Medicine
The Society of Nuclear Medicine is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of nuclear medicine and molecular imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances; provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed resource in the field of nuclear and molecular imaging: The Journal of Nuclear Medicine; sponsor research grants, fellowships and awards; and host the premiere nuclear medicine annual meeting. SNM members have developed--and continue to explore--biological and technological innovations in medicine to look noninvasively into the molecular basis of diseases to benefit countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at http://www.snm.org.
About Bio-Imaging Technologies Inc.
Bio-Imaging Technologies Inc. is a health care contract service organization providing services that support the product development process of the pharmaceutical, biotechnology and medical device industries. The company has specialized in assisting its clients in the design and management of the medical-imaging component of clinical trials since 1990. Bio-Imaging serves its clients on a global basis through its US Core Lab in Newtown, PA, its European Core Lab in Leiden, The Netherlands, and business offices in Massachusetts, the United Kingdom and Germany. Through its CapMed division, Bio-Imaging provides the Personal HealthKey™ technology and the Personal Health Record (PHR) software allowing patients to better monitor and manage their health care information.